Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Ketamine for Sickle Cell Vaso-occlusive Pain
NCT04150757Phase 3Terminated
- Start
- Dec 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in vaso-occlusive crisis (VOC). Started Dec 2019; status: terminated.
02
Drugs
ketamine
03
Conditions
vaso-occlusive crisis (VOC)
Beyond the preview
Go deeper on NCT04150757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150757.